TickerFactsScreenerDevelopers

Karyopharm Therapeutics Inc. (KPTI) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$84.39M2017: -$73.72M2018: -$159.12M2019: -$190.82M2020: -$160.23M2021: -$107.12M2022: -$149.55M2023: -$92.72M2024: -$127.49M2025: -$75.37M-$75.37M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$75.37M+40.9%
2024-$127.49M-37.5%
2023-$92.72M+38.0%
2022-$149.55M-39.6%
2021-$107.12M+33.2%
2020-$160.23M+16.0%
2019-$190.82M-19.9%
2018-$159.12M-115.8%
2017-$73.72M+12.6%
2016-$84.39M—